Open your mind to a new philosophy

Article

Didier Ducournau talks about the development and growth of the EVRS and on his personal vision for vitreoretinal surgeons.

Dr Didier Ducournau is what could only be described as a master of his art - vitreoretinal surgery. He has risen through the ranks to become one of Europe's best assets in the retina world, and today performs around 20 retina surgeries each day. In this exclusive interview, he speaks candidly about the experiences that have shaped him into the person he is today and reveals his inspiration for creating the society over which he currently presides - the European VitreoRetinal Society (EVRS).

"In 1999, I endured one of the worst experiences of my professional life. It occurred when I was invited to an Eastern European country to perform live surgery. I was asked to select some patients who I was to operate on the following day, from a group of 25, most of whom were monocular and suffered from severe diabetic retinopathy," explains Ducournau. "I realized the patients I'd turn away would probably never get the chance to be operated on again because, at the time, only one confirmed vitreoretinal surgeon operated in that country. Although I had no control over the situation, I felt that I was condemning them to blindness. Things needed to change," he insisted.

"Upon my return to France, I decided that a lifestyle change was required; to work part-time and dedicate my remaining spare time to sharing knowledge. My wife kindly agreed, even though it meant changing the lifestyle to which we had become accustomed. I then contacted Klaus Lucke from Bremen, who had also expressed his desire to set up a training school."

Feeling frustrated

At the time, only two types of meeting existed: those that allowed little time for free communication and discussion, where speaker invitations were often biased, and those that represented an exclusive meeting of the elite.

"I strongly believe that traditional societies need to evolve," insists Ducournau. "The real value in a society comes from the sharing of knowledge, techniques, concepts and philosophies. Those scientific societies, which are based on privilege, elitism and hierarchy, and participants pay to be seen amongst invited lectures, have lost their appeal. With EVRS, we have worked hard to pull away from this format. My true wish is that EVRS will be regarded as a place for generosity and sharing."

Ducournau admits to feeling frustrated. "Where is the real exchange of ideas? Why is basic teaching not offered?" he questions. "We needed to create something that took teaching back to basics and then through to the latest developments. It was our aim to provide a different and truly practical teaching of concepts and techniques, allowing the European retinologist to select the most suitable or adaptable approach to their own modus operandi. We also needed to encourage open mindedness; to create a space where new ideas were welcomed and not frowned upon. After all, we Europeans have a reputation for creativity and diversity and we needed to live up to it!"

Perfection is not realistic

According to Ducournau, this philosophy of sharing is not often instilled in the real world. A lecturer is often motivated to present because they want others to see how a procedure can be perfectly performed to yield the best possible results. This may be because they are new to their specialty field and want leaders to stop and take notice, or it may be because a once well-regarded surgeon wants to prove that they still belong in the elite. Either way, we all know that perfection is not constant. Things can and do go wrong and this mentality does not promote the sharing of knowledge, rather it boosts egos.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.